Edwards Lifesciences Aktie

Kaufen
Verkaufen
71,96 EUR +1,71 EUR +2,43 %
74,91 USD +1,00 USD +1,35 %
Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln! Du hast schon ein ZERO-Konto? Direkt handeln bei ZERO! Bei einem anderen Broker handeln Smartphone

Marktkap. 41,32 Mrd. EUR

KGV 33,13 Div. Rendite 0,00%

WKN 936853

ISIN US28176E1082

Symbol EW


Edwards Lifesciences Aktie Analyse

18.03.19 Edwards Lifesciences Buy Canaccord Adams
02.02.18 Edwards Lifesciences Buy Canaccord Adams
04.01.18 Edwards Lifesciences overweight Barclays Capital
27.07.17 Edwards Lifesciences Buy Stifel, Nicolaus & Co., Inc.
26.04.17 Edwards Lifesciences Outperform RBC Capital Markets
26.04.17 Edwards Lifesciences Buy Stifel, Nicolaus & Co., Inc.
26.10.16 Edwards Lifesciences Buy Stifel, Nicolaus & Co., Inc.
26.10.16 Edwards Lifesciences Outperform RBC Capital Markets
23.05.16 Edwards Lifesciences Buy Canaccord Adams
27.04.16 Edwards Lifesciences Buy Canaccord Adams
27.04.16 Edwards Lifesciences Outperform RBC Capital Markets
04.04.16 Edwards Lifesciences Buy Canaccord Adams
04.04.16 Edwards Lifesciences Buy Stifel, Nicolaus & Co., Inc.
04.04.16 Edwards Lifesciences Outperform RBC Capital Markets
29.07.15 Edwards Lifesciences Buy Stifel, Nicolaus & Co., Inc.
13.07.15 Edwards Lifesciences Outperform Northland Capital
13.07.15 Edwards Lifesciences Outperform RBC Capital Markets
12.06.15 Edwards Lifesciences Outperform BMO Capital Markets
09.12.14 Edwards Lifesciences Buy Canaccord Adams
09.12.14 Edwards Lifesciences Buy Stifel, Nicolaus & Co., Inc.
09.12.14 Edwards Lifesciences Outperform Northland Capital
24.10.14 Edwards Lifesciences Buy Stifel, Nicolaus & Co., Inc.
24.10.14 Edwards Lifesciences Outperform Northland Capital
06.12.12 Edwards Lifesciences outperform RBC Capital Markets
20.11.12 Edwards Lifesciences buy Stifel, Nicolaus & Co., Inc.
23.10.12 Edwards Lifesciences buy Jefferies & Company Inc.
22.10.12 Edwards Lifesciences outperform RBC Capital Markets
10.10.12 Edwards Lifesciences outperform RBC Capital Markets
01.10.12 Edwards Lifesciences buy Jefferies & Company Inc.
15.06.12 Edwards Lifesciences buy Jefferies & Company Inc.
15.06.12 Edwards Lifesciences buy Citigroup Corp.
12.12.11 Edwards Lifesciences outperform RBC Capital Markets
12.12.11 Edwards Lifesciences buy Citigroup Corp.
14.10.11 Edwards Lifesciences outperform RBC Capital Markets
24.08.11 Edwards Lifesciences outperform Morgan Keegan & Co., Inc.
10.08.11 Edwards Lifesciences buy Goldman Sachs Group Inc.
25.07.11 Edwards Lifesciences outperform Morgan Keegan & Co., Inc.
31.05.11 Edwards Lifesciences outperform RBC Capital Markets
12.04.11 Edwards Lifesciences overweight Barclays Capital
15.12.10 Edwards Lifesciences buy UBS AG
15.12.10 Edwards Lifesciences overweight Barclays Capital
27.10.10 Edwards Lifesciences overweight Barclays Capital
06.10.10 Edwards Lifesciences overweight Barclays Capital
24.09.10 Edwards Lifesciences outperform RBC Capital Markets
24.09.10 Edwards Lifesciences overweight Barclays Capital
24.09.10 Edwards Lifesciences overweight Piper Jaffray & Co.
22.07.10 Edwards Lifesciences outperform RBC Capital Markets
12.07.10 Edwards Lifesciences kaufen William Blair
22.04.10 Edwards Lifesciences kaufen Goldman Sachs Group Inc.
11.12.09 Edwards Lifesciences outperform Credit Suisse Group